PepGen Inc.

US$2.47As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PEPGHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (28.84%)
Div yield —
ROE (75.45%)
Biotechnology
Beta (5Y) 2.02
PE TTM —
TSR TTM (47.00%)
Mkt cap US$171.1M
ROIC (42.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.60
5.38%
(28.80%)
Buy 10|5|1|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
32.54%
22.03%
20.81%
14.27%
Revenue$M
13.74
14.30
14.58
14.89
(2.31%)
2.78%
6.50%
8.44%
Peers (US$171.1M)
Cap (US$)
PE
176.9M
—
165.9M
—
170.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.357
(0.042)
(0.046)
EBIT/Intx
0.567
2.893
2.919
Own earn%
(292.73)
67.45
38.30
Sh yield%
25.97
27.73
28.50
Owners
Insiders/Inst%
11.97
34.45
Short interest%
4.98
SBC / revenue%
0.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
5–10
$1 testx
0.0
Incr. ROIC%
3